Business Wire

Passwords on the Rise Despite Evidence That They Are Increasingly Unable to Protect, Finds Thales

6.5.2020 09:00:00 EEST | Business Wire | Press release

Share

According to the 2020 Thales Access Management Index – Europe and Middle East Edition 1 nearly a third (29%) of organisations in Europe and the Middle East still see usernames and passwords as one of the most effective means to protect access to their IT infrastructure, two years after the inventor of the complex static password admitted they don’t work. In fact, 67% of respondents indicate that their organisations plan to expand its use of usernames and passwords in the future. This continued reliance on outdated security comes despite IT leaders revealing it is increasingly easier (48%) to sell the need for security to their boards compared to last year (29%).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200505005035/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Thales)

Surveying 400 IT decision-makers across Europe and the Middle East, Thales’s new research found that the majority (57%) of IT professionals revealed that unprotected infrastructure is one of the biggest targets for cyber-attacks. Therefore any organization utilising it, as a result of business pressure driving them to adopt digital transformation technologies, are likely to be putting themselves at a higher level of risk.

Solving the Security vs. Convenience Conundrum

With the Covid-19 global pandemic causing many companies to work from home, IT departments are battling to provide employees with both security and convenience. In fact, over two-thirds (67%) of European IT leaders say their security teams feel under pressure to provide convenient access to applications and cloud services for users, but still maintain security – an indication they’re struggling to balance their digital transformation and security priorities. To this end, 96% believe that strong authentication and access management solutions can facilitate secure cloud adoption. Over three-quarters (76%) also revealed employee authentication needs to be able to support secure access to a broad range of services including virtual private networks and cloud applications.

Making small improvements

While some organisations still rely on legacy authentication methods like usernames and passwords, growing awareness of the threats is prompting action with almost all (94%) organizations having changed their security policies around access management in the last 12 months. Staff training on security and access management (47%), increasing spend on access management (43%), and access management becoming a board priority (37%), have all seen an increased focus. This is set to pay off in compliance terms too, with nearly all (98%) European respondents admitting controlling who has access to their company’s data. This will help them meet data regulation requirements like GDPR.

“As more and more businesses move to adopt cloud-based services for CRM, email, employee collaboration and IT infrastructure as part of their digital transformation strategies, the struggle to extend old solutions, designed to protect internal resources, to the outside world becomes very problematic. Often, in an effort to adapt to the new working habits of users connecting from anywhere, which is increasingly pertinent right now and will become standard moving forward, businesses tend to revert back to old password-based logins for cloud services in despair. This is knowingly increasing their security exposure to credential stuffing and phishing attacks,” said Francois Lasnier, Vice President for Access Management solutions at Thales.

Two steps forward, one step back

Looking ahead, some IT leaders are set to potentially use their influence at board level more wisely, with investment in the use of more secure methods such as biometric authentication (75%) and smart SSO (81%) set to increase in the next year. However, a third (67%) still plan to expand their use of usernames and passwords, which is a similar size to those intending to further utilise passwordless authentication methods (70%).

“For a long time, the biggest battle IT leaders have faced is increasing board awareness around taking the threat of security seriously,” Lasnier continued. “Now that they have that buy in, the focus should be on highlighting the importance access management plays in implementing a zero trust security policy to their executive management. With this in place, risk management professionals will be able to put in place a ‘Protect Everywhere - Trust Nobody’ approach as they expand in the cloud.”

1 The 2020 Access Management Index, is a survey of 400 executives in 7 countries in Europe and the Middle East with responsibility for, or influence over, IT and data security. The survey, reporting and analysis was conducted by Vanson Bourne , commissioned by Thales.

About Thales

Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 80,000 employees in 68 countries, Thales generated sales of €18.4 billion in 2019.

Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments.

PLEASE VISIT

Thales Group
Security
Download HD photos

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS CONTACT
Thales, Media Relations
Security
Constance Arnoux
+33 (0)1 57 77 91 58
constance.arnoux@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye